Back to search

Article

TORC1 inhibition as an immunotherapy to reduce infections in the elderly

2017-12-11

Abstract excerpt

mTOR inhibition extends lifespan and ameliorates aging-related pathologies including declining immune function in model organisms. The objective of this Phase 2a clinical trial was to determine if low dose mTOR inhibitor therapy enhanced immune function and thereby decreased infection rates in elderly subjects. The results indicate that 6 weeks of treatment with a low dose combination of a catalytic (BEZ235) plus...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fab3391d-8ab1-5bc5-911f-ab9ee9412665
DOI
10.1101/230813
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
TORC1 inhibition as an immunotherapy to reduce infections in the elderlyDOI 10.1101/230813
Select a neighboring publication to make it the new centre.